Today, the Misli Premier League continues with two critical matches in the XX round. Azernews reports that the first game ...

Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing ...

Cancellations of NIH grant review panels, in particular, could affectcancer research grants and funding. In these NIH grant ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

CheckMate 649 trial showed sustained efficacy with frontline nivolumab plus chemotherapy vs chemotherapy alone in patients with gastric cancers.

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

PALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ: NASDAQ:GH), a precision oncology company with a market capitalization of ...

Emerson recently partnered with Laramie Energy to help the Colorado-based oil and gas producer comply with state and federal ...

Treating initially unresectable gastric or GEJ cancer with camrelizumab plus nab-POF led to an R0 resection rate of 75% in a phase 2 trial.